|
1231 |
Editorial
Enthalten in Ethik in der Medizin Bd. 10, 1.11.1998, Nr. 4, date:11.1998: 205
|
|
|
|
1232 |
Editorial
Enthalten in Ethik in der Medizin Bd. 10, 1.6.1998, Nr. 2, date:6.1998: 63
|
|
|
|
1233 |
Effect sizes in ongoing randomized controlled critical care trials
Enthalten in Critical care Bd. 21, 5.6.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
1234 |
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial
Enthalten in BMC neurology Bd. 17, 10.1.2017, Nr. 1, date:12.2017: 1-11
|
|
|
|
1235 |
Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials
Enthalten in BMC nephrology Bd. 18, 30.6.2017, Nr. 1, date:12.2017: 1-11
|
|
|
|
1236 |
Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis
Enthalten in Cardiovascular diabetology Bd. 16, 27.2.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
1237 |
Effektive Hilfe für Ihre Patientin
Enthalten in MMW - Fortschritte der Medizin Bd. 159, 26.9.2017, Nr. 16, date:9.2017: 71
|
|
|
|
1238 |
Effektivität und Sicherheit von Alvimopan zur Wiederherstellung der Darmfunktion bei Patienten nach radikaler Zystektomie
Enthalten in Der Urologe / Ausgabe A Bd. 57, 2.2.2018, Nr. 2, date:2.2018: 207-210
|
|
|
|
1239 |
Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data
Enthalten in Cardiovascular diabetology Bd. 16, 21.3.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
1240 |
Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial
Enthalten in BMC musculoskeletal disorders Bd. 18, 30.8.2017, Nr. 1, date:12.2017: 1-10
|
|
Administration
